Pseudoephedrine hydrochloride and Otitis - a phase IV clinical study of FDA data
Otitis is reported only by a few people who take Pseudoephedrine Hydrochloride.
The phase IV clinical study analyzes which people take Pseudoephedrine hydrochloride and have Otitis. It is created by eHealthMe based on reports of 181 people who have side effects while taking Pseudoephedrine hydrochloride from the FDA, and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
181 people reported to have side effects when taking Pseudoephedrine hydrochloride.
Among them, 3 people (1.66%) have Otitis.
What is Pseudoephedrine hydrochloride?
Pseudoephedrine hydrochloride has active ingredients of pseudoephedrine hydrochloride. It is often used in nasal congestion. eHealthMe is studying from 846 Pseudoephedrine hydrochloride users for its effectiveness, alternative drugs and more.
What is Otitis?
Otitis (ear infection) is found to be associated with 2,351 drugs and 1,575 conditions by eHealthMe.
Number of Pseudoephedrine hydrochloride and Otitis reports submitted per year:
Gender of people who have Otitis when taking Pseudoephedrine hydrochloride *:
- female: 100 %
- male: 0.0 %
Age of people who have Otitis when taking Pseudoephedrine hydrochloride *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
Common drugs people take besides Pseudoephedrine hydrochloride *:
- Ventolin: 3 people, 100.00%
- Spiriva: 2 people, 66.67%
- Spiriva Respimat: 2 people, 66.67%
- Nucala: 2 people, 66.67%
- Paxil: 2 people, 66.67%
- Prilosec: 2 people, 66.67%
- Singulair: 2 people, 66.67%
- Wellbutrin: 2 people, 66.67%
- Dulera: 2 people, 66.67%
- Triamcinolone: 2 people, 66.67%
Common side effects people have besides Otitis *:
- Upper Respiratory Tract Infection: 2 people, 66.67%
- Lower Respiratory Tract Infection: 2 people, 66.67%
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 66.67%
- Oropharyngeal Pain: 1 person, 33.33%
- Headache (pain in head): 1 person, 33.33%
- Fever: 1 person, 33.33%
- Dermatitis Contact (skin reaction (dermatitis) resulting from exposure to allergens): 1 person, 33.33%
Common conditions people have *:
- Immunodeficiency Common Variable: 1 person, 33.33%
* Approximation only. Some reports may have incomplete information.
Do you take Pseudoephedrine hydrochloride and have Otitis?Check whether Otitis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Pseudoephedrine hydrochloride:
- Pseudoephedrine hydrochloride (846 reports)
Otitis treatments and more:
- Otitis (26,207 reports)
COVID vaccines that are related to Otitis:
- Otitis in Moderna COVID Vaccine
- Otitis in Pfizer BioNTech Covid Vaccine
- Otitis in Johnson and Johnson Covid Vaccine
How severe was Otitis and when was it recovered:
Expand to all the drugs that have ingredients of pseudoephedrine hydrochloride:
Common drugs associated with Otitis:
All the drugs that are associated with Otitis:
- Otitis (2,351 drugs)
Common conditions associated with Otitis:
All the conditions that are associated with Otitis:
- Otitis (1,575 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on pseudoephedrine hydrochloride (the active ingredients of Pseudoephedrine hydrochloride) and Pseudoephedrine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.